Stigmasterol's Role in Treating Acute Pancreatitis
Author Information
Author(s): Zhao Xuanlin, Li Fan, Wen Ao, Yu Xiuxian, Xu Xinrui, Wan Chengyu, Cao Yu, Xin Guang, Huang Wen
Primary Institution: West China Hospital, Sichuan University, Chengdu, China
Hypothesis
Stigmasterol might promote the transformation of pancreatic acinar cells from necrosis to apoptosis, providing therapeutic potential in acute pancreatitis.
Conclusion
Stigmasterol exhibits a significant protective effect against acute pancreatitis by enhancing acinar cell apoptosis through modulation of the ERK signaling pathways.
Supporting Evidence
- Stigmasterol treatment significantly reduced serum levels of lipase and amylase in the STC-induced acute pancreatitis model.
- Histological examination showed that stigmasterol mitigated pancreatic tissue injury.
- Stigmasterol treatment increased the ratio of Bcl-2/Bax, indicating enhanced apoptosis in pancreatic acinar cells.
Takeaway
Stigmasterol, a natural compound, helps protect the pancreas from damage during inflammation by encouraging healthy cell death instead of harmful cell death.
Methodology
The study used network pharmacology combined with experimental verification in a sodium taurocholate-induced acute pancreatitis mouse model.
Limitations
The study primarily used a sodium taurocholate-induced model, which may not fully represent all types of acute pancreatitis seen in humans.
Participant Demographics
Male C57BL/6 mice, weighing 23–25 g and aged 6–8 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website